ALIOS BIOPHARMA
Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).
ALIOS BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2006-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.aliosbiopharma.com
Total Employee:
51+
Status:
Active
Contact:
650-635-5500
Email Addresses:
[email protected]
Total Funding:
74.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Mobile Non Scaleable Content
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Vascugen
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series B - Alios BioPharma
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Alios BioPharma
Roche Venture Fund
Roche Venture Fund investment in Series B - Alios BioPharma
Novo Ventures
Novo Ventures investment in Series B - Alios BioPharma
Novo Holdings
Novo Holdings investment in Venture Round - Alios BioPharma
Roche Venture Fund
Roche Venture Fund investment in Series A - Alios BioPharma
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Alios BioPharma
Novo Ventures
Novo Ventures investment in Series A - Alios BioPharma
Novo Ventures
Novo Ventures investment in Series A - Alios BioPharma
Roche Venture Fund
Roche Venture Fund investment in Series A - Alios BioPharma
Official Site Inspections
http://www.aliosbiopharma.com
- Host name: a6033b2998aeb1ff7.awsglobalaccelerator.com
- IP address: 99.83.186.106
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
